Published • loading... • Updated
Innova’s Laguna Thrombectomy System Evaluated in TRUST Pivotal Study for PE Indication
Summary by Endovascular Today
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Innova’s Laguna Thrombectomy System Evaluated in TRUST Pivotal Study for PE Indication
October 6, 2026—Innova Vascular, Inc. announced results from its pivotal TRUST study evaluating the treatment of pulmonary embolism (PE) with the company’s Laguna thrombectomy system. According to the company, the TRUST study was conducted to evaluate the Laguna platform for a potential expansion of its indication for use to include the treatment of PE. On August 31, the company announced completion of patient enrollment in the study. The Laguna…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
